These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16088828)

  • 1. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans.
    Sandgren A; Albiger B; Orihuela CJ; Tuomanen E; Normark S; Henriques-Normark B
    J Infect Dis; 2005 Sep; 192(5):791-800. PubMed ID: 16088828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.
    Sjöström K; Spindler C; Ortqvist A; Kalin M; Sandgren A; Kühlmann-Berenzon S; Henriques-Normark B
    Clin Infect Dis; 2006 Feb; 42(4):451-9. PubMed ID: 16421787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.
    Brueggemann AB; Griffiths DT; Meats E; Peto T; Crook DW; Spratt BG
    J Infect Dis; 2003 May; 187(9):1424-32. PubMed ID: 12717624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of clonal and serotype-specific properties on the invasive capacity of Streptococcus pneumoniae.
    Sandgren A; Sjostrom K; Olsson-Liljequist B; Christensson B; Samuelsson A; Kronvall G; Henriques Normark B
    J Infect Dis; 2004 Mar; 189(5):785-96. PubMed ID: 14976594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virulence of Streptococcus pneumoniae may be determined independently of capsular polysaccharide.
    Mizrachi Nebenzahl Y; Porat N; Lifshitz S; Novick S; Levi A; Ling E; Liron O; Mordechai S; Sahu RK; Dagan R
    FEMS Microbiol Lett; 2004 Apr; 233(1):147-52. PubMed ID: 15043881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae.
    Blomberg C; Dagerhamn J; Dahlberg S; Browall S; Fernebro J; Albiger B; Morfeldt E; Normark S; Henriques-Normark B
    J Infect Dis; 2009 Apr; 199(7):1032-42. PubMed ID: 19203261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.
    Jansen AG; Rodenburg GD; van der Ende A; van Alphen L; Veenhoven RH; Spanjaard L; Sanders EA; Hak E
    Clin Infect Dis; 2009 Jul; 49(2):e23-9. PubMed ID: 19522653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commonly invasive serotypes of Streptococcus pneumoniae trigger a reduced innate immune response compared with serotypes rarely responsible for invasive infection.
    Burgess TS; Hirschfeld AF; Tyrrell GJ; Bettinger JA; Turvey SE
    FEMS Immunol Med Microbiol; 2008 Jun; 53(1):136-9. PubMed ID: 18248437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expansion and evolution of Streptococcus pneumoniae serotype 19A ST320 clone as compared to its ancestral clone, Taiwan19F-14 (ST236).
    Hsieh YC; Lin TL; Chang KY; Huang YC; Chen CJ; Lin TY; Wang JT
    J Infect Dis; 2013 Jul; 208(2):203-10. PubMed ID: 23559465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of capsular and clonal types and beta-lactam resistance to the severity of experimental pneumococcal meningitis.
    Ribes S; Taberner F; Cabellos C; Tubau F; Ardanuy C; Gerber J; Liñares J; Nau R; Gudiol F
    Microbes Infect; 2008 Feb; 10(2):129-34. PubMed ID: 18248756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
    J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine.
    Pichon B; Bennett HV; Efstratiou A; Slack MP; George RC
    Epidemiol Infect; 2009 Jul; 137(7):1049-56. PubMed ID: 19161642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of pneumococcal phase variants in invasive human infections.
    Serrano I; Melo-Cristino J; Ramirez M
    BMC Microbiol; 2006 Jul; 6():67. PubMed ID: 16872486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is different about serotype 1 pneumococci?
    Ritchie ND; Mitchell TJ; Evans TJ
    Future Microbiol; 2012 Jan; 7(1):33-46. PubMed ID: 22191445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines.
    Laval CB; de Andrade AL; Pimenta FC; de Andrade JG; de Oliveira RM; Silva SA; de Lima EC; Fabio JL; Casagrande ST; Brandileone MC
    Clin Microbiol Infect; 2006 Jan; 12(1):50-5. PubMed ID: 16460546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies.
    Saeland E; Vidarsson G; Jonsdottir I
    Microb Pathog; 2000 Aug; 29(2):81-91. PubMed ID: 10906263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsule Promotes Intracellular Survival and Vascular Endothelial Cell Translocation during Invasive Pneumococcal Disease.
    Brissac T; Martínez E; Kruckow KL; Riegler AN; Ganaie F; Im H; Bakshi S; Arroyo-Diaz NM; Spencer BL; Saad JS; Nahm MH; Orihuela CJ
    mBio; 2021 Oct; 12(5):e0251621. PubMed ID: 34634940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J; Moine P; Azoulay-Dupuis E; Henin D; Fantin B
    Eur Cytokine Netw; 2007 Mar; 18(1):23-30. PubMed ID: 17400535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Invasive pneumococcal disease in children aged <5 years admitted to 3 urban hospitals in Ibadan, Nigeria.
    Falade AG; Lagunju IA; Bakare RA; Odekanmi AA; Adegbola RA
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S190-6. PubMed ID: 19191615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.